Company intelligence / Profile preview

Zenufa

Kinshasa, Democratic Republic of Congo

Ownership: Private
Employees: ~37
Development stage: Other

Overview

Zenufa manufactures and distributes a wide range of pharmaceutical products—antibiotics, antimalarials, analgesics, and other essential generics—for East and Central African markets. It operates cGMP facilities in DRC and Tanzania and has a significant presence as both a manufacturer and distributor. No clinical trial drug development or investigational clinical results reported; products are marketed as generics and branded generics[1][2][4].

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Has distributed/imported for PfizerPharmacia UpjohnGlaxo WellcomeSmithKline Beecham

Beyond the preview

Go deeper on Zenufa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zenufa.

Explore the full profile